Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 795

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 795
---
 313,772for the three and nine months ended September 30, 2024, due to the estimated change in fair value of the bifurcated embedded derivative liability. (In the condensed consolidated statements of operations for the three and nine months ended September 30, 2024, and 2023 previously filed by the Company in a Form 8-K/A filed with the SEC on November 14, 2024, the $ 21,229gain was inadvertently set forth in parentheses, and such parentheses have been removed herein.) The related discount is amortized to interest expense over the term of the debt using the effective yield method. Amortization expense related to the debt discount totaled $ 668,838and $ 1,107,010for the three and nine months ended September 30, 2024. Interest expense, inclusive of the debt discount amortization, on the Notes totaled $ 2,002,886and $ 3,615,466for the three and nine months ended September 30, 2024.

Note 8—Stockholders’ equity

As of September 30, 2024, the Company had two classes of stock defined in its Amended and Restated Articles of Incorporation (the “Articles).

Common Stock – The Company is authorized to issue up to 300,000,000shares of Common Stock based on the Articles. Holders of common stock are entitled to one vote for each share of common stock.

Preferred Stock – The Company is authorized to issue up to 150,000,000 shares of Preferred Stock based on the Articles. The Company has three classes of Preferred Stock: Series A, Series A-1, and Series B. See below for a summary of the rights and preferences for the Company’s Preferred Stock:

| i. | Accrues dividends whether or not declared, are cumulative, and are payable only if declared by the Board of Directors. The Series A and SeriesA-1preferred stock accrue dividends at a rate of $0.0208and $0.0264, per annum respectively. Accrued, but unpaid Series A andA-1dividends totaled approximately $6,530,000as of September 30, 2024. The Series B preferred stock accrues dividends at a rate of $0.066for the first two years. After the second anniversary, Series B stock accrues dividends at a rate of $0.0264per annum. Accrued but unpaid Series B dividends